These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22724242)

  • 1. [Combination therapy; dobutamine and milrinone].
    Kato M; Hirayama A
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():428-33. PubMed ID: 22724242
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we use outpatient dobutamine or milrinone?
    Kato M; Sanada S; Kitakaze M
    Circ Heart Fail; 2009 Jul; 2(4):377-8. PubMed ID: 19808362
    [No Abstract]   [Full Text] [Related]  

  • 3. [Additive effects of milrinone and dobutamine in severe heart failure].
    Meissner A; Herrmann G; Gerdesmeyer L; Simon R
    Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure treated with low-dose milrinone in a full-term newborn.
    Sebková S; Tomek V; Zemanová P; Janota J
    Prague Med Rep; 2012; 113(1):58-65. PubMed ID: 22373807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intravenous milrinone in left ventricular restoration.
    Yamaguchi A; Tanaka M; Naito K; Kimura C; Kobinata T; Okamura H; Ino T; Adachi H
    Ann Thorac Cardiovasc Surg; 2009 Aug; 15(4):233-8. PubMed ID: 19763054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital in the home.
    Montalto M
    Aust Fam Physician; 2011 Apr; 40(4):183, 185. PubMed ID: 21744523
    [No Abstract]   [Full Text] [Related]  

  • 8. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
    Mager G; Klocke RK; Volkmann A; Kux A; Höpp HW; Hilger HH
    Z Kardiol; 1991 Feb; 80(2):149-57. PubMed ID: 2058247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure.
    Jennings DL; Thompson ML
    Ann Pharmacother; 2009 Nov; 43(11):1872-6. PubMed ID: 19789358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent inotropes for advanced heart failure: inquiring minds want to know.
    Silver MA
    Am Heart J; 1999 Aug; 138(2 Pt 1):191-2. PubMed ID: 10426825
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intravenous positive inotropic therapy on myocardial damage in patients with dilated cardiomyopathy.
    Albayrak F; Demircan S; Yazici M; Arslandağ M
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):69. PubMed ID: 18258539
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A; Schmelzle T; Simon R
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catecholamines use in patients with heart failure].
    Iino K; Ito H
    Nihon Rinsho; 2007 May; 65 Suppl 5():30-3. PubMed ID: 17571362
    [No Abstract]   [Full Text] [Related]  

  • 16. Extended release oral milrinone as an adjunct to heart failure therapy.
    Nanayakkara S; Bergin P; Mak V; Crannitch K; Kaye DM
    Intern Med J; 2017 Aug; 47(8):973-974. PubMed ID: 28782207
    [No Abstract]   [Full Text] [Related]  

  • 17. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
    Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S
    Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
    Rieg AD; Schroth SC; Grottke O; Hein M; Ackermann D; Rossaint R; Schälte G
    Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
    Saab G; Mindel G; Ewald G; Vijayan A
    Am J Kidney Dis; 2002 Aug; 40(2):E7. PubMed ID: 12148128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
    Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.